NEW YORK, NY / ACCESSWIRE / November 14, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Viking Therapeutics, Inc. ("Viking" or the "Company") (NASDAQ:VKTX). Such investors are ...
Be Nutty: “Nuts are an excellent choice for controlling inflammation,” say experts at the University of North Carolina. “They ...
While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback